Unplanned early implantable port removal – Full Text

“Implantable port catheters are vital for cancer treatment, but complications such as infections and mechanical failures pose challenges. Lymphoma and leukemia patients’ unique cellular abnormalities may influence these risks. This study aimed to determine whether the underlying disease or varying degrees of cytopenia increase the risk of unplanned early port removal” Lu et al (2025).
Implantable port removal outcomes pilot study

“The primary end point of any future research on TIVAD maintenance should primarily be focused on the functionality of the TIVAD. The CINAS classification effectively standardizes reporting of TIVAD functionality” Douchy et al (2025).
Femoral venous access port case study – Full Text

“In an adolescent male with relapsed primary mediastinal lymphoma, complicated by complete SVC obstruction, we report the placement of a port into the right femoral vein by interventional radiology” Lian et al (2025).
Contrast injection via implantable port

“To compare the contrast enhancement (CE) value, injection rate and contrast material (CM) volume with and without the implanted port system during dynamic hepatic computed tomography (CT) scan” Moriwake et al (2025).
Patient satisfaction with implantable ports

“Patients expressed high satisfaction with low impact on comfort, psychological state and physical well-being. Maintenance experiences varied, highlighting the need for further investigation and a validated comprehensive questionnaire” Goossens et al (2025).
Ultrasound-guided infusion port implantation via axillary vein – Full Text

“Transaxillary vein ultrasound-guided implantation of a TIVAP is a low-risk, high efficiency procedure with low rate of complication” Tian et al (2025).
Safety-engineered port access needles – Full Text

“We have shown significant differences regarding product characteristics of safety mechanisms of port access needles. Our evaluation approach provides specific data for both, technical (e.g., single-handed activation) and personal device selection criteria (e.g., preference of the safety mechanism)” Gabler et al (2025).
Difficulty removing a totally implantable venous access port – Full Text

“This case highlights the challenges of removing TIVAPs inserted via the internal jugular vein, particularly when the catheter traverses the sternocleidomastoid muscle. Repeated neck movements might lead to significant adhesions around the catheter, complicating its removal” Chen et al (2025).
Exercise protocol for cancer patients with PICC-PORT

“Exercise management for cancer patients with arm peripherally inserted central catheter-PORT (PICC-PORT) requires standardization to prevent complications and optimize outcomes” Le et al (2025).
Totally implantable access port complications

“To investigate the risk factors for complications in breast cancer patients with totally implantable access ports (TIAPs)” Fan et al (2025).
Quality of life in cancer patients with chest ports

“This study aims to evaluate the satisfaction and health-related quality of life (HRQoL) in cancer patients with chest ports and to understand their experiences and challenges” Nie et al (2025).
Repositioning of malpositioned infusion port catheter – Full Text

“Infusion port catheter malposition, where the catheter tip is located in vessels other than the superior vena cava, is a rare complication of port implantation. This can lead to infusion difficulties or port-related thrombosis” Guo et al (2025).
How to adjust a dislodged implanted port

“A 50-year-old lady receiving venous port implantation for chemotherapy was found with a catheter disconnected from the port and dislodged into the right ventricle” Guo et al (2025).
Vein access points for IV port implantation

“To compare the safety and efficacy of the Internal Jugular Vein and the Axillary Vein access points for port-a-cath implantation in cancer patients undergoing systemic intravenous treatments” Pignataro et al (2025).
Port access needle evaluation – Full Text

“We have shown significant differences regarding product characteristics of safety mechanisms of port access needles. Our evaluation approach provides specific data for both, technical (e.g., single-handed activation) and personal device selection criteria (e.g., preference of the safety mechanism)” Gabler et al (2025).
Virtual reality for patients during subcutaneous implantable access port placement

“In conclusion, our results suggest that virtual reality may serve as a non-pharmacological alternative to reduce anxiety during PAC implantation, decrease sedation requirements, and maintain patient satisfaction regarding the quality of care” Novials et al (2025).
Safe removal of totally implanted central venous access devices – Full Text

“This paper describes a standardized protocol (SaRePo: Safe Removal of Ports) which consists of seven basic strategies to be adopted systematically during removal of totally implanted venous access devices, so to minimize the risk of adverse events” Annetta et al (2025).
Virtual reality for informed consent for implantable port placement – Full Text

“Clinical feasibility and the effects of head-mounted VR devices on motion sickness and educational quality were evaluated in adult oncology patients enrolled in an intravenous (IV) port placement intervention study” Tsai et al (2025).
Implantable port placed by translumbar approach

“This report highlights the successful placement of a CV port by translumbar approach in a patient with advanced esophageal carcinoma complicated by SVCS” Maruo et al (2025).
Implantable port evaluation in breast cancer patients – Full Text

“The use of Totally Implantable Venous Access Port (TIVAP) has gained importance in chemotherapy for cancer patients due to its ability to reduce complications compared to conventional central venous catheters” Guo et al (2025).
Patient satisfaction with implantable venous access ports – Full Text

“Long-term totally implantable venous access ports (TIVAP) are essential for administering chemotherapy and parenteral nutrition in cancer patients. This study aimed to evaluate patient satisfaction and postoperative complications, compared to existing literature, emphasizing patient-reported outcomes (PRO) as a critical factor in treatment decisions” Werba et al (2025).
Support with implanted venous access port care at home – Full Text

“Cancer patients with an implanted venous access port (IVAP) often manage their care at home during chemotherapy intervals, including maintaining the device, monitoring complications, and following medication instructions” Jia et al (2025).
Vein puncture technique for totally implantable venous access ports – Full Text

“To assess the clinical efficacy of a new single-incision axillary vein puncture technique for implanting totally implantable venous access ports (TIVAPs)” Mu et al (2025).
Placement of totally implantable venous access devices in oncology practice – Full Text

“Despite the initial censure, his idea garnered interest across the Atlantic in the US, where Andre Counard and Dickinson Richards, in the 1940s, refined his technique and used it for cardiovascular research. In 1956, Forsmann, Counard and Richards were awarded the Nobel Prize in Physiology for their work on central venous access” Ong and Anil (2025).
Choosing insertion site for totally implantable venous access ports in children

“Compared with internal jugular vein, external jugular vein access has obvious advantages: the location of external jugular vein is superficial and easy to find, the utilization of external jugular vein is easy to learn and master, and the external jugular vein is of little importance to the human body” Zhen et al (2025).
Radiation exposure in pediatric port implantations – Full Text

“The objective of the present study was to establish local reference data for radiation exposure in children undergoing port implantation” Krause et al (2025).
Comparison between arm port and chest port

“This study reveals no significant differences in the incidence of infections, catheter occlusion, thrombosis, exudation, fibrin sheath, catheter malposition, fracture, pneumothorax, and malfunction between the two implanted venous access ports” Wei et al (2025).
Latest research on totally implantable venous access ports – Full Text

“Therefore, this article aims to provide a systematic overview of the clinical applications and maintenance of TIVAP, both domestically and internationally” Huang et al (2025).
Port implantation in a non-surgical setting – Full Text

“The cost incurred for port implantations by medical oncologists was lower (994.38 € cheaper for each device) compared to those implanted by vascular radiologists. Our experience suggests that implantation of port devices by medical oncologist in a non-surgical environment is safe and cost saving regarding conventional procedures” Revuelta et al (2025).
Radiologic placement of totally implantable venous access devices – Full Text

“TIVAD implantation via the jugular vein under radiological guidance provides a safe, reliable and convenient means of long-term venous access in oncology patients” Tashi et al (2024).